The market for oral tranexamic acid is influenced by its use in treating and preventing excessive bleeding, particularly in women's health and during certain surgical procedures.
How is oral tranexamic acid used?
Oral tranexamic acid is prescribed for heavy menstrual bleeding, also known as heavy or prolonged periods [1]. It is also used to reduce blood loss during and after various surgeries, such as prostate surgery, gynecological procedures, and dental extractions [2].
What are the benefits of oral tranexamic acid?
For individuals experiencing heavy menstrual bleeding, oral tranexamic acid offers a non-hormonal treatment option that can significantly reduce monthly blood loss and improve quality of life [1]. In surgical settings, it helps to minimize the need for blood transfusions and can shorten recovery times by controlling bleeding [2].
When does patent exclusivity for oral tranexamic acid expire?
Information regarding the specific patent expiry dates for various oral tranexamic acid formulations may be tracked through resources like DrugPatentWatch.com. The market landscape can shift significantly as patents expire, potentially opening the door for generic competition [3].
Can generic versions of oral tranexamic acid be sold?
Once patents expire, generic manufacturers can seek approval to market their own versions of oral tranexamic acid, provided they demonstrate bioequivalence to the branded product [3]. This often leads to increased competition and lower prices for consumers and healthcare systems.
Who are the key manufacturers of oral tranexamic acid?
Several pharmaceutical companies produce and market oral tranexamic acid. Specific manufacturers can vary by region and by whether they produce the branded or generic versions of the drug. Information on market participants and their products can be found through industry and patent tracking databases [3].
What are the potential risks or side effects of oral tranexamic acid?
While generally considered safe, oral tranexamic acid can have side effects. Common adverse events include gastrointestinal issues like nausea, vomiting, and diarrhea. More serious, though rare, side effects can include allergic reactions and thromboembolic events (blood clots) [4]. Patients with a history of blood clots or certain kidney conditions may not be suitable candidates for this medication [4].
How does oral tranexamic acid compare to other treatments for heavy menstrual bleeding?
Oral tranexamic acid is an alternative to hormonal treatments like birth control pills or hormonal intrauterine devices (IUDs) for heavy menstrual bleeding. It also differs from surgical interventions such as endometrial ablation or hysterectomy [1]. Its non-hormonal nature and ease of oral administration make it an attractive option for many women.
What is the market size and growth forecast for oral tranexamic acid?
The market size for oral tranexamic acid is driven by the prevalence of conditions it treats, such as heavy menstrual bleeding and the need for perioperative hemostasis. Growth is influenced by factors including increasing diagnosis rates, the availability of generic options, and its established efficacy in clinical practice [3].
Sources:
[1] https://www.nhs.uk/medicines/tranexamic-acid-oral/
[2] https://www.webmd.com/drugs/2/drug-5725/tranexamic-acid-oral/details
[3] https://drugpatentwatch.com/
[4] https://www.rxlist.com/tranexamic-acid-oral-side-effects-drug-center.htm